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Geriatric assessment is a requirement to effectively 
provide a quality radiotherapy service to the older person 
A. O'Donovan
1Trinity Centre for Health Sciences, Discipline of Radiation 
Therapy, Dublin 8, Ireland Republic of 
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Most European countries are currently faced by a major 
demographic shift that will see increasing numbers of older 
patients. This represents a corresponding increase in the 
number of older patients presenting for radiation therapy. It 
is recognised that this will require “age attuning” of our 
cancer treatment services to provide a more holistic 
approach to the care of older patients. Comprehensive 
Geriatric Assessment (CGA) or Geriatric Assessment (GA) as 
used in the oncology literature, can identify risk factors for 
adverse outcomes in older cancer patients. CGA was designed 
to more accurately detect frailty in older patients, and both 
the National Comprehensive Cancer Network (NCCN) and 
International Society of Geriatric Oncology (SIOG) 
recommend its use in Oncology. CGA includes a compilation 
of reliable and valid tools to assess geriatric domains such as 
comorbidity, functional status, physical performance, 
cognitive status, psychological status, nutritional status, 
medication review, and social support. The benefits of CGA 
include greater diagnostic accuracy, reduced hospitalisation 
and improved survival and quality of life. Benefits for cancer 
patients include predicting complications of treatment, 
estimating survival and detection of problems not found using 
standard oncology performance measures, such as 
performance status. Cancer treatment is a physiologic 
stressor, and its impact on older patients is poorly defined in 
relation to baseline reserve capacity. GA provides a means of 
quantifying known heterogeneity in older patients, and may 
identify problems that could potentially be reversed, or 
better managed, in order to improve outcomes. Despite the 
evidence demonstrating the benefits of GA in improving the 
health status of older patients, its adoption in (radiation) 
oncology has not been widespread. The published literature 
lacks a standardised approach to GA in Oncology, making 
interpretation of the current evidence difficult. Exacerbating 
this issue is the traditional exclusion of older patients from 
clinical trials. GA has the potential to predict toxicity, 
survival and quality of life in older patients, and further 
research is needed to clarify its role. GA is known to be time 
and resource intensive, and recent studies have sought to 
develop shorter screening tools specifically for oncology 
patients, such as the G8. However, none of these approaches 
have been validated to date, with one obvious drawback 
being the lack of comparison in the form of a “gold standard” 
comprehensive approach. One potential solution to resource 
and time issues is the sharing of responsibility among the 
multidisciplinary team, with radiation therapists having a 
valuable role to play as front line staff. Recent focus in policy 
documents on measures to improve the quality of healthcare 
for older patients has resulted in a need to adequately 
prepare qualified health professionals to work together in a 
more collaborative manner. Many international models of 
Geriatric Oncology exist, however implementation is 
institution-specific and must take account of existing 
resources and infrastructure. In addition, there is currently 
no formal Geriatric Oncology fellowship scheme in most 
countries (apart from the US) or education programme in 
place for oncology professionals on how to best implement 
geriatric assessment. Many healthcare professionals, do not 
receive any training in the fundamental principles of geriatric 
medicine and how they may apply to their profession. The 
aim of this presentation is to present a critical overview of 
the current literature on GA in radiation oncology, and 
previous research by the authors in this field. It will also 
incorporate aspects of feasibility and requirements for a 
geriatric oncology service. The latter will include educational 
aspects and the need for adapted curricula in radiation 
oncology to incorporate aspects of aging, optimal treatment 
and attitudes towards aging. 
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· The evidence for treatment ofolder patients with breast 
cancer is scarce due to lack of clinical trials andselective 
inclusion of patients 
· Older patients are less willing totrade quality of life for 
absolute survival gain, but data that can providepatients with 
information concerning these outcomes are lacking 
· The recently performed “FOCUS onChoice” study has shown 
that older patients choose a mastectomy more 
frequentlythan younger patients  
· Recent trials suggest thatradiotherapy can be omitted in 
older patients with low-risk tumours 
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Palliative radiation therapy in geriatric cancer patients 
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What is the Young ESTRO Committee and what can it do for 
young radiation oncology professionnals? 
J.E. Bibault
1Hôpital Européen Georges Pompidou, Radiation Oncology 
Department, Paris, France 
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The Young Task Force 
The first YTF was formed in 2011 at the Anniversary 
congressbased on the decision of the ESTRO Steering 
Committee of 16 June 2009. At thebeginning, members of the 
YTF were appointed by the Board each year. In 2012,at the 
Agorá meeting, YTF members’ term was changed to three 
years, renewableonce. This meeting allowed for “strategic 
discussions”, bringing young,promising RT scientists / 
professionals together with the core ESTROleadership. The 
Agorá meeting provided valuable input for the YTF. Several 
projectsrealised by the YTF were based on the results of the 
Agorá meeting. 
The first chair of the YTF, Daniel Zips, thought that theaim of 
the YTF, from the start, was to become a committee and be 
an integralpart of ESTRO governance contributing to 
activities and supporting the youngmembers. The Young task 
force (YTF) is a key structure in securing thelong-term future 
of ESTRO. The 3rd YTF succeeded in initiating several 
projects(e.g. revision of YTF structure, involvement in ESTRO 
committees, improvementof online communication, etc.). To 
carry on these essential activities, the YTFwas changed to 
become a full ESTRO Committee in 2015. 
Composition of the Young Committee 
The Young Committee reflects the diversity 
andmultidisciplinarity of ESTRO with members from clinical 
radiation oncology,radiobiology, physics and RTTs. Each 
member also acts as an observer in one ofthe other standing 
committee of ESTRO: 
• Jean-Emmanuel Bibault (Paris, France): National Societies 
Committee 
• Gerben Borst (Amsterdam, The Netherlands) : Clinical 
Committee 
• Laura Mullaney (Dublin, Ireland): RTT Committee 
• Kasper Rouschop (Maastricht, The Netherlands): 
Radiobiology Committee 
• Maximilian Schmid (Vienna, Austria): GEC-ESTRO 
Brachytherapy Committee 
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• Mateusz Spalek (Warsaw, Poland): ACROP Committee 
• Daniela Thorwarth (Tübingen, Germany): Physics 
Committee 
• Wouter van Elmpt (Maastricht, The Netherlands): Physics 
Committee 
Future vision: carry on the activities initiated by theprevious 
task Forces and work on new perspectives 
Standing committee involvement 
Young Committee members’ positions as observers allow us 
torepresent the interests of the young ESTRO members and to 
evaluate thecontribution and participation of the young 
members in other standingcommittees’ activities. 
Young scientist session at ESTRO Forum and Young 
scientisttrack at numbered ESTRO congresses 
The Young Committee is responsible for the 
organisation,contribution and promotion of the young 
scientist session / track at all ESTROcongresses. Each year, a 
young track is held with symposia and teachinglectures aimed 
at the young radiation oncology professionals, with 
subjectssuch as “how to build a career”, “how to write a 
good article/abstract”. Wealso organize a young reception at 
the end of the track, which is always a nicemoment to meet 
other young Europeans and network with each other.  
Online services (Facebook, videos, FALCON, DOVE, 
scientificnetworking) 
The 3rd YTF started several projects regarding 
onlineservices. The main task will be to maintain, promote 
and communicate theseactivities. The Young Committee will 
also contribute to ESTRO online serviceslike FALCON, DOVE, 
etc. 
ESTRO Fellow 
In regard of the heterogeneous training in the field 
ofradiation oncology within Europe, the “ESTRO Fellow” was 
created to achieve ahigh level of education as well as reflect 
a high dedication towards ESTRO. Ithas become a prestigious 
mark of distinction.  
The next ESTRO fellow exam will take place on April, 
29th2016 at ESTRO35 in Turin. The Application deadline is set 
for March, 29th 2016. 
The future 
The Young Committee is currently involved in the setup ofthe 
3rd Agora Meeting which should take place late 2015 or early 
2016. Thismeeting will bring together motivated young ESTRO 
members to discuss andexchange our vision for our field. A 
call for applications will be sent in thatperspective. 
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The Young Radiation Oncologists Group (YROG) is a working 
party of the European Organization for Research and 
Treatment of Cancer (EORTC) -Radiation Oncology Group 
(ROG). Its members are the "young members" of the ROG.  
The YROG was initiated in 2012 with an aim to incorporate 
radiation oncologists in early phases of their career within 
the EORTC- ROG activities. This was done to have a new 
generation of radiation oncologists actively involved in 
research. 
Joining the YROG is an opportunity to present your research 
and new study proposals and to take part in the discussions 
held at the different ROG working parties. By being a part of 
the EORTC-ROG you will learn about designing clinical trials 
and have a chance to work side by side with world-leaders in 
oncology.  
If you are at the early stages of your career in radiation 
oncology and are looking for an opportunity to be involved in 
key research, come to hear about the YROG.  
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Since 2003, the SFjRO (French Society of young Radiation 
Oncologist) promote radiation oncology teaching in France. 
The goals of our society are to promote and ease the 
teaching of radiation oncology by developing relationships 
between residents and professors. By creating specific tools, 
giving access to scientific journals and organizing each year 
two theoretical courses, the SFjRO aims to give access to a 
better understanding of current practices in Radiation 
Oncology. Nowadays our society has more than 200 members. 
Each year French residents attend one national radiation 
therapy courses covering each fundamental field of radiation 
oncology : radioanatomy, radiobiology, radiophysics and 
brachytherapy and a summer school dedicated to a specific 
organ. All these courses are available freely on our website 
which has now a database of more than 300 radiation 
oncology courses. The SFjRO works with SFRO (French Society 
of Radiation Oncologists) and organize a young session during 
the National meeting of Radiation oncology. We also 
represent resident in front of national organisation such as 
National cancer Institute (Inca) and National Board of 
Oncology Teachers (CNEC). Another goal of SFjRO is to 
promote research among residents and we have published 
several studies about delineation variability, burnout or 
mobile technology and social media use by young radiation 
oncologists. In the future we hope to strengthen our 
cooperation with European young radiation oncologist 




The Young AIRO (Italian Association of Radiation Oncology) 
Group 
D. Greto
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The Young AIRO group (yAIRO) is a part of the Italian 
Association of radiation oncology composed by members 
below 40 years old. The increasing participation of the young 
member to the AIRO scientific activities resulted in the 
foundation of the Young group in 2007. The main purpose of 
the yAIRO was to create a network connections between 
junior physicians working in different institutions throughout 
the country, to promote the collaboration with junior groups 
of other national scientific societies in the field of oncology. 
Nowadays the Young group has approximately 350 members. 
Every years there is an annual scientific national event 
dedicated to young members, a scientific session dedicated 
to the young members takes place during the AIRO national 
meeting. One of the main project of the yAIRO is to create 
collaboration programs with other young specialists involved 
in the oncology field. In the last years, relationships were 
created with the young group of the Italian medical oncology 
association (AIOM), young urologists (SIURO) and young 
medical radiologists (SIRM). The yAIRO published some 
collaborative research projects: the INTER-ROMA Project 
(2011), the BUONGIORNO Project (2013), the PROCAINA part I 
and II Project (2013), the STYRO Project (2013), the PEDRO 
project (2015). A project about the history and development 
of Italian radiation oncology residency programs and one 
about the pacemaker and implanted cardioverter 
defibrillator management in radiation therapy are in 
progress. The fundamental role of young members in the 
Italian radiation oncology society will induce yAIRO to 
improve young specialists’ participation, involvement and 
commitment into education, research and clinical care. 
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